Authors: NIJLAND EA STRASBURGER CJ POPPSNIJDERS C VANDERWAL PS VANDERVEEN EA

Citation: Ea. Nijland et al., A 5 DAY TREATMENT WITH DAILY SUBCUTANEOUS INJECTIONS OF GROWTH HORMONE-RELEASING PEPTIDE-2 CAUSES RESPONSE ATTENUATION AND DOES NOT STIMULATE INSULIN-LIKE GROWTH-FACTOR-I SECRETION IN HEALTHY-YOUNG MEN, European journal of endocrinology, 139(4), 1998, pp. 395-401

Authors: VANDERWAL PS DRAEGER KE VANIPEREN AM MARTINI C AARSEN M HEINE RJ

Citation: Ps. Vanderwal et al., BETA-CELL RESPONSE TO ORAL GLIMEPIRIDE ADMINISTRATION DURING AND FOLLOWING A HYPERGLYCEMIC CLAMP IN NIDDM PATIENTS, Diabetic medicine, 14(7), 1997, pp. 556-563

Authors: VANDERWAL PS SCHEEN A VANGAAL L SCHMITT H HEINE RJ

Citation: Ps. Vanderwal et al., EVALUATION OF GLYCEMIC CONTROL IN NIDDM PATIENTS TREATED WITH ORAL HYPOGLYCEMIC AGENTS VERSUS COMBINATION WITH NPH INSULIN, Diabetologia, 40, 1997, pp. 1358-1358

Authors: VANDERWAL PS DEVILLE W HEINE RJ

Citation: Ps. Vanderwal et al., PREDICTORS OF GLYCEMIC EFFICACY OF 4 TREATMENT STRATEGIES IN NIDDM PATIENTS WITH SECONDARY FAILURE TO ORAL HYPOGLYCEMIC AGENTS, Diabetologia, 39, 1996, pp. 804-804

Authors: VANDERWAL PS SCHEEN A VANGAAL L SCHMITT H HEINE RJ

Citation: Ps. Vanderwal et al., EFFICACY OF BEDTIME NPH INSULIN ALONE, AS COMPARED TO COMBINATION WITH METFORMIN AND OR GLIPIZIDE IN NIDDM PATIENTS WITH SECONDARY FAILURE TO ORAL HYPOGLYCEMIC AGENTS/, Diabetes, 45, 1996, pp. 1059-1059

Authors: NIJPELS G VANDERWAL PS BOUTER LM HEINE RJ

Citation: G. Nijpels et al., COMPARISON OF 3 METHODS FOR THE QUANTIFICATION OF BETA-CELL FUNCTION AND INSULIN SENSITIVITY, Diabetes research and clinical practice, 26(3), 1994, pp. 189-195